Unum Therapeutics Inc (UMRX) Stock Analyst Ratings
NASDAQ:UMRX - Nasdaq -
ChartMill assigns a Buy % Consensus number of 87% to UMRX. The Buy consensus is the weighted average rating of the current analysts ratings.
UMRX was analyzed by 3 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about UMRX.
In the last month the buy percentage rose by 7 points. So the trust of analysts is improving.
Only 3 analysts analyzed UMRX. So this is just the average opinion of a couple of analysts.